Lexicon Pharmaceuticals
(NASDAQ) LXRX
Lexicon Pharmaceuticals Financials at a Glance
Market Cap
$1.08B
Revenue (TTM)
$69.64M
Net Income (TTM)
$26.09M
EPS (TTM)
$-0.07
P/E Ratio
-34.13
Dividend
$0.00
Beta (Volatility)
1.61 (High)
Dividend
$0.00
Beta (Volatility)
1.61 (High)
Price
$2.33
Volume
77,549
Open
$2.37
Price
$2.33
Volume
77,549
Open
$2.37
Previous Close
$2.33
Daily Range
$2.29 - $2.38
52-Week Range
$0.51 - $2.53
Dividend
$0.00
Beta (Volatility)
1.61 (High)
Price
$2.33
Volume
77,549
Open
$2.37
Previous Close
$2.33
Daily Range
$2.29 - $2.38
52-Week Range
$0.51 - $2.53
LXRX News
LXRX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Lexicon Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
81
CEO
Michael Exton, PhD
Website
www.lexpharma.comHeadquarters
The Woodlands, TX 77381, US
LXRX Financials
Key Financial Metrics (TTM)
Gross Margin
99%
Operating Margin
-35%
Net Income Margin
-37%
Return on Equity
-16%
Return on Capital
-9%
Return on Assets
-10%
Earnings Yield
-2.93%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.08B
Shares Outstanding
444.20M
Volume
77.55K
Avg. Volume
2.67M
Financials (TTM)
Gross Profit
$49.53M
Operating Income
$48.91M
EBITDA
$48.29M
Operating Cash Flow
$67.85M
Capital Expenditure
$0.00
Free Cash Flow
$67.85M
Cash & ST Invst.
$96.23M
Total Debt
$62.24M
Lexicon Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$21.10M
+1572.1%
Gross Profit
$20.99M
+1604.1%
Gross Margin
99.49%
N/A
Market Cap
$1.08B
N/A
Market Cap/Employee
$10.52M
N/A
Employees
103
N/A
Net Income
$1.04M
+95.9%
EBITDA
$996.00K
+95.7%
Quarterly Fundamentals
Net Cash
$112.95M
+21.3%
Accounts Receivable
$11.78M
-75.2%
Inventory
$276.00K
+37.3%
Long Term Debt
$56.06M
-4.4%
Short Term Debt
$1.64M
-96.2%
Return on Assets
-9.71%
N/A
Return on Invested Capital
-9.36%
N/A
Free Cash Flow
$14.73M
+66.4%
Operating Cash Flow
$14.73M
+66.4%